Cargando…
Just Price for PCSK9 Inhibitors: No less, No More
See Article by Ko et al.
Autor principal: | Nasir, Khurram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404214/ https://www.ncbi.nlm.nih.gov/pubmed/30571392 http://dx.doi.org/10.1161/JAHA.118.010884 |
Ejemplares similares
-
PCSK9 Inhibitors: What Lies Beyond Monoclonal Antibodies?
por: EBioMedicine
Publicado: (2015) -
JAK Inhibitors — More Than Just Glucocorticoids
por: Stebbing, Justin, et al.
Publicado: (2021) -
Cundurango at Less Price
Publicado: (1871) -
Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives
por: Arrieta, Alejandro, et al.
Publicado: (2017) -
The discovery of PCSK9 inhibitors: A tale of creativity and multifaceted translational research
por: Elguindy, Ahmed, et al.
Publicado: (2013)